At a glance
- Originator Sawai
- Class Antihyperglycaemics
- Mechanism of Action Beta 3 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 06 Aug 2003 No development reported - Preclinical for Diabetes mellitus in Japan (unspecified route)
- 16 May 2000 Preclinical development for Diabetes mellitus in Japan (Unknown route)